IndraLab

Statements


RAB35 binds USP32. 2 / 2
| 2

sparser
"Recent research has revealed that the USP32-Rab35 axis is crucial for controlling treatment resistance in gastrointestinal stromal tumors."

sparser
"Their research suggests that individuals with gastrointestinal stromal tumors resistant to imatinib may benefit from focusing on the USP32-Rab35 axis as a potential therapeutic target."